Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 370

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Improved Methods of Retroviral Vector Transduction and Production for Gene Therapy

Kotani, Hitoshi, Newton, Perry B., Zhang, Shuyuan, Chiang, Yawen L., Otto, Edward, Weaver, Linda, Blaese, R. Michael, Anderson, W. French, McGarrity, Gerard J. · 1994 · Human Gene Therapy

Abstract

To facilitate clinical applications of retroviral-mediated human gene transfer, retroviral vectors must be of high titer and free of detectable replication-competent retroviruses. The purpose of this study was to optimize methods of retroviral vector production and transduction. Studies were conducted using 22 retroviral vector producer cell lines. Inactivation of retroviral vectors was greater at 37°C than at 32°C. A 5- to 15-fold increase of vectors was produced at 32°C compared to 37°C; the vector increase at 34°C was intermediate. For example, PA317/G1Na.40 grew to a titer of 1.8 × 107 cfu/ml at 32°C, compared to 5.0 × 105 cfu/ml at 37°C. The production of retroviral vectors was scalable achieving similar results in flasks, roller bottles, or a CellCube Bioreactor. Retroviral vectors were concentrated 15–24 times with vector recovery ranging from 91 to 96% in a Pellicon tangential flow filtration system. Retroviral supernatants were successfully lyophilized. The combination of glucose or sorbitol with gelatin resulted in recovery rates of 64–83%. In studies on transduction by retroviral vectors, centrifugation of vector supernatants onto target cells significantly increased transduction efficiency as measured by vector titration for G418 resistance, fluorescence-activated cell sorting (FACS), and polymerase chain reaction (PCR) analyses. The combination of the above methods has significantly increased the growth and transduction by this vector system. For expanded clinical trials using retroviral-mediated gene transfer, large volumes of vector will be needed at the highest possible titers. Factors that influence large-scale production of retroviral vector need to be defined. The presentation of Kotani et al. identifies some factors that influence growth, concentration, transduction, and freeze drying of these vectors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/hum.1994.5.1-19

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 370

Metadata

Authors
Kotani, H., Newton, P. B., Zhang, S., Chiang, Y. L., Otto, E., Weaver, L., Blaese, R. M., Anderson, W. F., & McGarrity, G. J.
Venue
Human Gene Therapy
Published
1994-01
Volume
5
Issue
1
Pages
19-28
ISSN
  • 1043-0342 (ISSN-L)
  • 1557-7422
OpenAlex
W1997582694
Cited by
370
References
16
FWCI
14.09
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.